Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 4 Ureteral Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1

Interventions

pembrolizumab 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 enfortumab vedotin 1 cabozantinib 1 avelumab 1 Watchful Waiting 1 Observation 1 Cystoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ureteral Neoplasms × Cystoscopy × 30 days × Clear all

NCT03244384 2026-05-29

AMBASSADOR

National Cancer Institute (NCI)

Phase 3 Active not recruiting

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡